Brofaromine in major depressed patients: A controlled clinical trial versus Imipramine and open follow-up of up to one year
- 30 November 1992
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 26 (3) , 163-172
- https://doi.org/10.1016/0165-0327(92)90012-u
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tolerability and antidepressive effect of brofaromine, a short-acting reversible MAO inhibitor — an open studyEuropean Neuropsychopharmacology, 1991
- A European Study of Views on the Use of Monoamine Oxidase InhibitorsThe British Journal of Psychiatry, 1989
- The Prophylactic Efficacy of Fluoxetine in Unipolar DepressionThe British Journal of Psychiatry, 1988
- Duration of Antidepressant Drug TreatmentArchives of General Psychiatry, 1984
- Characterization of a New, Short-Acting and Specific Inhibitor of Type A Monoamine OxidasePublished by S. Karger AG ,1982
- Depression Subtypes and Response to Phenelzine, Diazepam, and a PlaceboArchives of General Psychiatry, 1974
- Clinical Trial of the Treatment of Depressive IllnessBMJ, 1965
- DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPYAmerican Journal of Psychiatry, 1964
- Treatment of Anxiety States by Antidepressant DrugsBMJ, 1962
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960